Eurofins Scientific SE (0MV5.IL)
IOB - IOB Delayed price. Currency in EUR
Add to watchlist
As of 09:17AM BST. Market open.
| Previous close | 56.80 |
| Open | 56.20 |
| Bid | 54.80 x 0 |
| Ask | 57.60 x 0 |
| Day's range | 55.74 - 56.64 |
| 52-week range | 44.87 - 64.98 |
| Volume | |
| Avg. volume | 189,602 |
| Market cap | 12.579B |
| Beta (5Y monthly) | 0.59 |
| PE ratio (TTM) | 24.75 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 1.00 (2.03%) |
| Ex-dividend date | 04 Jul 2023 |
| 1y target est | N/A |
- Business Wire
Eurofins Scientific SE: Purchases of Own Shares From the 29th of April 2024 to the 3rd of May 2024
LUXEMBOURG, May 06, 2024--Regulatory News: Eurofins Scientific SE (Paris:ERF):
- Business Wire
Eurofins Scientific SE: Purchases of Own Shares From the 25th to the 26th of April 2024
LUXEMBOURG, April 29, 2024--Regulatory News: Eurofins Scientific SE (Paris:ERF):
- Business Wire
Eurofins Achieves Organic Growth of 6.8% in Q1 2024, Ahead of Its Objectives
LUXEMBOURG, April 24, 2024--Regulatory News: The Eurofins (Paris:ERF) network of companies continues to deliver resilient growth:Reported revenues in Q1 2024 totalled €1,653m, an increase of 5.0% vs Q1 2023, driven by solid organic growth but slightly restrained by FX (-1.0%). The period also comprised nearly one less public working day, an effect that will mostly reverse in Q2 2024.Adjusted for public working days in Q1 2024, organic revenue growth7 in the Core Business (excluding COVID-19 rela
© 2024 Yahoo. All rights reserved.